IMIQUIMOD

IMIQUIMOD was reported 2334 times

These side effects are most commonly reported by patients taking IMIQUIMOD:

# Side effect Count
0 OFF LABEL USE 265
1 ERYTHEMA 185
2 FATIGUE 181
3 PRODUCT USE IN UNAPPROVED INDICATION 177
4 DRUG INEFFECTIVE 171
5 PAIN 137
6 NAUSEA 114
7 INFLUENZA LIKE ILLNESS 103
8 APPLICATION SITE ERYTHEMA 102
9 HEADACHE 95
10 PRURITUS 88
11 PYREXIA 85
12 SCAB 77
13 APPLICATION SITE PAIN 75
14 MALAISE 75
15 DIARRHOEA 74
16 ASTHENIA 69
17 DIZZINESS 68
18 CHILLS 64
19 RASH 64
20 CONDITION AGGRAVATED 62
21 ANXIETY 57
22 DECREASED APPETITE 55
23 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55
24 ARTHRALGIA 52
25 BACK PAIN 50
26 MYALGIA 50
27 SKIN ULCER 49
28 DYSPNOEA 48
29 APPLICATION SITE SCAB 47
30 PRODUCT USE ISSUE 47
31 SKIN IRRITATION 47
32 OEDEMA 42
33 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40
34 SKIN EXFOLIATION 40
35 SKIN REACTION 39
36 PAIN IN EXTREMITY 37
37 BLISTER 36
38 INFLAMMATION 36
39 PNEUMONIA 36
40 VOMITING 36
41 CHRONIC KIDNEY DISEASE 35
42 INSOMNIA 35
43 ACUTE KIDNEY INJURY 34
44 BASAL CELL CARCINOMA 34
45 TREATMENT FAILURE 34
46 APPLICATION SITE PRURITUS 33
47 DRUG INTERACTION 33
48 MUSCLE SPASMS 33
49 EMOTIONAL DISTRESS 32
50 DRUG RESISTANCE 31
51 GAIT DISTURBANCE 31
52 RENAL FAILURE 31
53 SKIN LESION 31
54 THERAPY PARTIAL RESPONDER 31
55 DEATH 30
56 DRY SKIN 30
57 WEIGHT DECREASED 30
58 APPLICATION SITE DISCOLOURATION 29
59 DISEASE PROGRESSION 29
60 FALL 29
61 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28
62 ALOPECIA 27
63 EYE IRRITATION 27
64 APPLICATION SITE IRRITATION 26
65 BURNING SENSATION 26
66 COUGH 26
67 SKIN EROSION 26
68 ANHEDONIA 25
69 APPLICATION SITE SWELLING 25
70 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25
71 APPLICATION SITE INFLAMMATION 24
72 DEPRESSION 24
73 HYPOTENSION 24
74 LIP SWELLING 24
75 PATHOGEN RESISTANCE 24
76 PRODUCT DOSE OMISSION ISSUE 24
77 URTICARIA 24
78 APPLICATION SITE ULCER 23
79 DYSGEUSIA 23
80 LYMPHADENOPATHY 23
81 MUSCULAR WEAKNESS 23
82 APPLICATION SITE REACTION 22
83 APPLICATION SITE VESICLES 22
84 HYPERSENSITIVITY 22
85 OROPHARYNGEAL PAIN 22
86 THERAPY NON-RESPONDER 22
87 CHEST PAIN 21
88 ABDOMINAL PAIN 20
89 ACTINIC KERATOSIS 20
90 ERYTHEMA MULTIFORME 20
91 SKIN PLAQUE 20
92 SWELLING 20
93 ABDOMINAL PAIN UPPER 19
94 FEELING ABNORMAL 19
95 HAEMORRHAGE 19
96 PERIPHERAL SWELLING 19
97 SKIN DISORDER 19
98 ANAEMIA 18
99 APPLICATION SITE HAEMORRHAGE 18
100 CONSTIPATION 18
101 HYPERTENSION 18
102 INFECTION 18
103 PEMPHIGUS 18
104 PSORIASIS 18
105 STEVENS-JOHNSON SYNDROME 18
106 VISION BLURRED 18
107 ABDOMINAL DISCOMFORT 17
108 APPLICATION SITE DISCHARGE 17
109 HERPES ZOSTER 17
110 HYPONATRAEMIA 17
111 INFLUENZA 17
112 KAPOSI^S SARCOMA 17
113 SKIN DEPIGMENTATION 17
114 SQUAMOUS CELL CARCINOMA 17
115 TREATMENT NONCOMPLIANCE 17
116 ADVERSE DRUG REACTION 16
117 APPLICATION SITE EROSION 16
118 ECONOMIC PROBLEM 16
119 LOSS OF CONSCIOUSNESS 16
120 RASH ERYTHEMATOUS 16
121 SKIN PAPILLOMA 16
122 SWELLING FACE 16
123 ANOGENITAL WARTS 15
124 COVID-19 15
125 ORAL PAIN 15
126 SQUAMOUS CELL CARCINOMA OF SKIN 15
127 STOMATITIS 15
128 VERTIGO 15
129 ACCIDENTAL EXPOSURE TO PRODUCT 14
130 BONE DENSITY DECREASED 14
131 DISEASE RECURRENCE 14
132 ILLNESS 14
133 MOLLUSCUM CONTAGIOSUM 14
134 NASOPHARYNGITIS 14
135 PRODUCT PRESCRIBING ISSUE 14
136 STAPHYLOCOCCAL INFECTION 14
137 APPLICATION SITE SCAR 13
138 ATRIAL FIBRILLATION 13
139 DEHYDRATION 13
140 DISCOMFORT 13
141 DRUG HYPERSENSITIVITY 13
142 GAIT INABILITY 13
143 HYPERHIDROSIS 13
144 LETHARGY 13
145 LIP BLISTER 13
146 NEUTROPENIA 13
147 OSTEOPOROSIS 13
148 PARAESTHESIA 13
149 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13
150 PRODUCT PACKAGING QUANTITY ISSUE 13
151 SINUSITIS 13
152 SKIN BURNING SENSATION 13
153 SKIN DISCOLOURATION 13
154 SOMNOLENCE 13
155 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13
156 ULCER 13
157 URINARY TRACT INFECTION 13
158 APPLICATION SITE EXFOLIATION 12
159 DRUG INTOLERANCE 12
160 EYE SWELLING 12
161 HYPOAESTHESIA 12
162 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12
163 INCORRECT DOSE ADMINISTERED 12
164 MUSCULOSKELETAL STIFFNESS 12
165 NO ADVERSE EVENT 12
166 RENAL IMPAIRMENT 12
167 RHINORRHOEA 12
168 SYNCOPE 12
169 SYSTEMIC LUPUS ERYTHEMATOSUS 12
170 VISUAL IMPAIRMENT 12
171 APPLICATION SITE DRYNESS 11
172 COGNITIVE DISORDER 11
173 END STAGE RENAL DISEASE 11
174 INJECTION SITE PAIN 11
175 INTENTIONAL PRODUCT MISUSE 11
176 LEUKOPENIA 11
177 LUPUS-LIKE SYNDROME 11
178 MOUTH ULCERATION 11
179 NEUROPATHY PERIPHERAL 11
180 OSTEONECROSIS 11
181 OSTEOPENIA 11
182 PANCYTOPENIA 11
183 POLLAKIURIA 11
184 RASH PAPULAR 11
185 THERAPY CESSATION 11
186 TINNITUS 11
187 WOUND SECRETION 11
188 ACNE 10
189 ASTHMA 10
190 CHEILITIS 10
191 DERMATITIS ATOPIC 10
192 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10
193 DRY EYE 10
194 EYE PRURITUS 10
195 GENERAL PHYSICAL HEALTH DETERIORATION 10
196 HERPES SIMPLEX 10
197 HYPERKERATOSIS 10
198 LIP PAIN 10
199 ORAL HERPES 10
200 PAIN OF SKIN 10
201 PAPILLOMA VIRAL INFECTION 10
202 PLATELET COUNT DECREASED 10
203 PRODUCT QUALITY ISSUE 10
204 PULMONARY EMBOLISM 10
205 SCAR 10
206 SEPTIC SHOCK 10
207 THERAPEUTIC RESPONSE UNEXPECTED 10
208 WHITE BLOOD CELL COUNT DECREASED 10
209 AGITATION 9
210 ANGINA PECTORIS 9
211 BALANCE DISORDER 9
212 BRONCHITIS 9
213 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 9
214 CONFUSIONAL STATE 9
215 DEMENTIA 9
216 DERMOID CYST 9
217 DRUG DOSE OMISSION 9
218 DYSPHAGIA 9
219 EYE PAIN 9
220 HAEMOGLOBIN DECREASED 9
221 HALLUCINATION 9
222 INTERNATIONAL NORMALISED RATIO INCREASED 9
223 LOCAL REACTION 9
224 MIGRAINE 9
225 NIGHT SWEATS 9
226 OCULAR HYPERAEMIA 9
227 ORAL DISCOMFORT 9
228 OVERDOSE 9
229 RETCHING 9
230 SEPSIS 9
231 SLEEP DISORDER 9
232 TREMOR 9
233 APHTHOUS ULCER 8
234 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8
235 FLUSHING 8
236 GASTROOESOPHAGEAL REFLUX DISEASE 8
237 INTENTIONAL PRODUCT USE ISSUE 8
238 JOINT SWELLING 8
239 LACRIMATION INCREASED 8
240 MALIGNANT NEOPLASM PROGRESSION 8
241 MEDICATION ERROR 8
242 METASTATIC MALIGNANT MELANOMA 8
243 NASAL CONGESTION 8
244 NECK PAIN 8
245 PSORIATIC ARTHROPATHY 8
246 RASH MACULAR 8
247 RASH PRURITIC 8
248 SECRETION DISCHARGE 8
249 SKIN NECROSIS 8
250 WEIGHT INCREASED 8
251 BLOOD CREATININE INCREASED 7
252 BLOOD PRESSURE ABNORMAL 7
253 CARDIOTOXICITY 7
254 CATARACT 7
255 CELLULITIS 7
256 DERMATITIS 7
257 DERMATITIS CONTACT 7
258 DIABETES MELLITUS 7
259 DISTURBANCE IN ATTENTION 7
260 DRUG EFFECT INCOMPLETE 7
261 DRY MOUTH 7
262 DYSPEPSIA 7
263 DYSPHONIA 7
264 EJECTION FRACTION DECREASED 7
265 EYELID OEDEMA 7
266 FLATULENCE 7
267 HEPATIC ENZYME INCREASED 7
268 INCORRECT DRUG ADMINISTRATION DURATION 7
269 INJECTION SITE ERYTHEMA 7
270 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7
271 MOTOR DYSFUNCTION 7
272 MULTIPLE FRACTURES 7
273 MUSCULOSKELETAL PAIN 7
274 NEPHROGENIC ANAEMIA 7
275 NEPHROLITHIASIS 7
276 OEDEMA PERIPHERAL 7
277 PALPITATIONS 7
278 PAPULE 7
279 PIGMENTATION DISORDER 7
280 PRODUCT DOSE OMISSION 7
281 PRODUCT STORAGE ERROR 7
282 PRODUCT SUBSTITUTION ISSUE 7
283 RIB FRACTURE 7
284 SCRATCH 7
285 SKIN FISSURES 7
286 SKIN HAEMORRHAGE 7
287 SURGERY 7
288 WOUND 7
289 ADVERSE EVENT 6
290 ADVERSE REACTION 6
291 APHASIA 6
292 BLOOD COUNT ABNORMAL 6
293 BLOOD PRESSURE INCREASED 6
294 CHEST DISCOMFORT 6
295 CROHN^S DISEASE 6
296 CUTANEOUS LUPUS ERYTHEMATOSUS 6
297 DELIRIUM 6
298 DYSURIA 6
299 EAR INFECTION 6
300 EAR PAIN 6
301 EPIDERMODYSPLASIA VERRUCIFORMIS 6
302 EXPIRED PRODUCT ADMINISTERED 6
303 FACIAL PAIN 6
304 FEELING HOT 6
305 GASTROINTESTINAL DISORDER 6
306 HYPERAEMIA 6
307 HYPOXIA 6
308 IMPAIRED HEALING 6
309 INTERNATIONAL NORMALISED RATIO ABNORMAL 6
310 KERATOACANTHOMA 6
311 MOVEMENT DISORDER 6
312 PLEURAL EFFUSION 6
313 PRODUCTIVE COUGH 6
314 SKIN CANCER 6
315 SKIN WEEPING 6
316 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 6
317 SWOLLEN TONGUE 6
318 TASTE DISORDER 6
319 TENDERNESS 6
320 THROAT IRRITATION 6
321 TRANSAMINASES INCREASED 6
322 UNEVALUABLE EVENT 6
323 UPPER RESPIRATORY TRACT INFECTION 6
324 URINARY RETENTION 6
325 VITILIGO 6
326 WHEEZING 6
327 ABDOMINAL DISTENSION 5
328 AGEUSIA 5
329 APPLICATION SITE BURN 5
330 APPLICATION SITE DISCOMFORT 5
331 APPLICATION SITE RASH 5
332 BLOOD IRON DECREASED 5
333 BONE LOSS 5
334 CARDIAC FAILURE CONGESTIVE 5
335 CARDIOVASCULAR DISORDER 5
336 CATATONIA 5
337 CONTUSION 5
338 DEAFNESS NEUROSENSORY 5
339 DEPRESSED MOOD 5
340 GLOSSODYNIA 5
341 HEART RATE INCREASED 5
342 HEPATOTOXICITY 5
343 HYPERPARATHYROIDISM SECONDARY 5
344 IMPAIRED QUALITY OF LIFE 5
345 INTERVERTEBRAL DISC PROTRUSION 5
346 IRRITABILITY 5
347 LEUKOENCEPHALOPATHY 5
348 LICHEN PLANUS 5
349 MALIGNANT MELANOMA 5
350 MOBILITY DECREASED 5
351 MULTIPLE-DRUG RESISTANCE 5
352 NEOPLASM MALIGNANT 5
353 NERVE INJURY 5
354 ORAL MUCOSAL BLISTERING 5
355 PNEUMONITIS 5
356 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5
357 PRODUCT PHYSICAL CONSISTENCY ISSUE 5
358 PRODUCT PRESCRIBING ERROR 5
359 PURULENCE 5
360 QUADRIPARESIS 5
361 RASH PUSTULAR 5
362 RENAL FAILURE ACUTE 5
363 RENAL TUBULAR ACIDOSIS 5
364 RENAL TUBULAR NECROSIS 5
365 RESPIRATORY TRACT INFECTION 5
366 ROAD TRAFFIC ACCIDENT 5
367 SKIN INFECTION 5
368 THERAPEUTIC RESPONSE DECREASED 5
369 THERAPEUTIC RESPONSE SHORTENED 5
370 THERAPY INTERRUPTED 5
371 THROMBOCYTOPENIA 5
372 TOXIC EPIDERMAL NECROLYSIS 5
373 TOXICITY TO VARIOUS AGENTS 5
374 UPPER LIMB FRACTURE 5
375 WHITE BLOOD CELL COUNT INCREASED 5
376 ACTIVITIES OF DAILY LIVING DECREASED 4
377 ALANINE AMINOTRANSFERASE INCREASED 4
378 ALTERED STATE OF CONSCIOUSNESS 4
379 AMNESIA 4
380 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4
381 APATHY 4
382 APPLICATION SITE HYPERSENSITIVITY 4
383 APPLICATION SITE PAPULES 4
384 ARRHYTHMIA 4
385 ARTHRITIS 4
386 ARTHROPATHY 4
387 BACTERIAL INFECTION 4
388 BEDRIDDEN 4
389 BLINDNESS 4
390 BLOOD ALKALINE PHOSPHATASE INCREASED 4
391 BLOOD URINE PRESENT 4
392 BONE METABOLISM DISORDER 4
393 BONE PAIN 4
394 BRADYCARDIA 4
395 BRAIN FOG 4
396 CANDIDA INFECTION 4
397 CARDIAC ARREST 4
398 CEREBROVASCULAR ACCIDENT 4
399 CHEMICAL BURN 4
400 CHRONIC PAPILLOMATOUS DERMATITIS 4
401 CONJUNCTIVAL HYPERAEMIA 4
402 CORONARY ARTERY DISEASE 4
403 DEAFNESS 4
404 DERMATITIS BULLOUS 4
405 DEVICE MALFUNCTION 4
406 DIPLOPIA 4
407 DRUG ADMINISTERED AT INAPPROPRIATE SITE 4
408 DRUG ADMINISTRATION ERROR 4
409 DRUG ERUPTION 4
410 DRUG PRESCRIBING ERROR 4
411 DYSPNOEA EXERTIONAL 4
412 FEAR 4
413 FEEDING DISORDER 4
414 FLUID RETENTION 4
415 FOOT FRACTURE 4
416 FUNGAL INFECTION 4
417 GENITAL ERYTHEMA 4
418 HIP FRACTURE 4
419 HOSPITALISATION 4
420 HYPOPHAGIA 4
421 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4
422 INJECTION SITE REACTION 4
423 LABORATORY TEST ABNORMAL 4
424 LIP DRY 4
425 LIP EROSION 4
426 LIP HAEMORRHAGE 4
427 LOCAL SWELLING 4
428 LUNG DISORDER 4
429 MANIA 4
430 MULTIPLE SCLEROSIS 4
431 MUSCULOSKELETAL CHEST PAIN 4
432 MYOCARDIAL INFARCTION 4
433 NEPHROPATHY TOXIC 4
434 NEUTROPHIL COUNT DECREASED 4
435 ORAL MUCOSA EROSION 4
436 PAIN IN JAW 4
437 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4
438 PAROSMIA 4
439 PHOTOPSIA 4
440 PRECANCEROUS SKIN LESION 4
441 PRODUCT DOSE OMISSION IN ERROR 4
442 PSEUDOMONAS INFECTION 4
443 RASH GENERALISED 4
444 RED BLOOD CELL COUNT DECREASED 4
445 RESPIRATORY FAILURE 4
446 RESPIRATORY TRACT CONGESTION 4
447 SKIN HYPOPIGMENTATION 4
448 SKIN SWELLING 4
449 STRESS 4
450 SUICIDAL IDEATION 4
451 TACHYCARDIA 4
452 THERAPEUTIC PRODUCT EFFECT DECREASED 4
453 THINKING ABNORMAL 4
454 THROAT TIGHTNESS 4
455 THROMBOSIS 4
456 TOOTH LOSS 4
457 VULVAR DYSPLASIA 4
458 XEROSIS 4
459 ABNORMAL DREAMS 3
460 ABSCESS 3
461 ACTIVITIES OF DAILY LIVING IMPAIRED 3
462 ALOPECIA TOTALIS 3
463 ANAL CANCER 3
464 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3
465 ANURIA 3
466 APHTHOUS STOMATITIS 3
467 APPLICATION SITE BLEEDING 3
468 APPLICATION SITE INFECTION 3
469 APPLICATION SITE WARMTH 3
470 ASPARTATE AMINOTRANSFERASE INCREASED 3
471 BACK INJURY 3
472 BACTERAEMIA 3
473 BLINDNESS UNILATERAL 3
474 BLOOD CREATINE PHOSPHOKINASE INCREASED 3
475 BLOOD DISORDER 3
476 BLOOD GLUCOSE INCREASED 3
477 BLOOD IMMUNOGLOBULIN G INCREASED 3
478 BODY TEMPERATURE INCREASED 3
479 BRAIN STEM SYNDROME 3
480 BREAST CANCER 3
481 BUSCHKE-LOWENSTEIN^S TUMOUR 3
482 CHAPPED LIPS 3
483 CHOLESTASIS 3
484 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3
485 CIRCULATORY COLLAPSE 3
486 CLOSTRIDIUM DIFFICILE COLITIS 3
487 CONJUNCTIVITIS 3
488 CRYING 3
489 DECREASED ACTIVITY 3
490 DRUG DISPENSING ERROR 3
491 DRUG EFFECT LESS THAN EXPECTED 3
492 DRUG LEVEL INCREASED 3
493 DUODENAL ULCER 3
494 ECTROPION 3
495 ECZEMA 3
496 EPILEPSY 3
497 EPISTAXIS 3
498 ERYTHRODERMIC PSORIASIS 3
499 EUPHORIC MOOD 3
500 EYE DISCHARGE 3
501 EYE DISORDER 3
502 FAECES DISCOLOURED 3
503 FEBRILE NEUTROPENIA 3
504 FLANK PAIN 3
505 GASTROINTESTINAL HAEMORRHAGE 3
506 GENITAL PAIN 3
507 GRANULOMATOUS DERMATITIS 3
508 HAND FRACTURE 3
509 HEPATIC ENZYME ABNORMAL 3
510 HERPES VIRUS INFECTION 3
511 HYPERSOMNIA 3
512 HYPERURICAEMIA 3
513 HYPOGEUSIA 3
514 HYPOKALAEMIA 3
515 IMMUNE SYSTEM DISORDER 3
516 IMPETIGO 3
517 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3
518 INFECTED SKIN ULCER 3
519 INTENTIONAL DOSE OMISSION 3
520 INTESTINAL OBSTRUCTION 3
521 IRON DEFICIENCY ANAEMIA 3
522 LACERATION 3
523 LICHENIFICATION 3
524 LICHENOID KERATOSIS 3
525 LIMB DISCOMFORT 3
526 LINEAR IGA DISEASE 3
527 LIP ERYTHEMA 3
528 LIP EXFOLIATION 3
529 LIP ULCERATION 3
530 LOWER RESPIRATORY TRACT INFECTION 3
531 MADAROSIS 3
532 MALIGNANT MELANOMA IN SITU 3
533 MATERNAL EXPOSURE DURING PREGNANCY 3
534 MIDDLE INSOMNIA 3
535 MULTI-ORGAN FAILURE 3
536 NECROSIS 3
537 NERVOUSNESS 3
538 NEUROLOGICAL DECOMPENSATION 3
539 OSTEOARTHRITIS 3
540 OXYGEN SATURATION DECREASED 3
541 PAGET^S DISEASE OF THE VULVA 3
542 PANCREATITIS 3
543 PENILE ERYTHEMA 3
544 PENIS DISORDER 3
545 PNEUMOTHORAX 3
546 POOR QUALITY SLEEP 3
547 PRODUCT DISPENSING ERROR 3
548 PRODUCT LABEL CONFUSION 3
549 PRURITUS GENERALISED 3
550 PULMONARY OEDEMA 3
551 PUNCTATE KERATITIS 3
552 PURULENT DISCHARGE 3
553 RENAL CYST 3
554 RENAL DISORDER 3
555 RENAL INJURY 3
556 RESPIRATORY DISORDER 3
557 RESPIRATORY DISTRESS 3
558 RETINAL DETACHMENT 3
559 RHABDOMYOLYSIS 3
560 RHEUMATOID ARTHRITIS 3
561 SECOND PRIMARY MALIGNANCY 3
562 SEIZURE 3
563 SELF-MEDICATION 3
564 SENSORY LOSS 3
565 SKELETAL INJURY 3
566 SKIN ABRASION 3
567 SKIN HYPERPIGMENTATION 3
568 SKIN HYPERTROPHY 3
569 SKIN TIGHTNESS 3
570 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3
571 SPINAL DISORDER 3
572 THERMAL BURN 3
573 TONGUE DISCOMFORT 3
574 TOOTH INFECTION 3
575 TRANSIENT ISCHAEMIC ATTACK 3
576 TRANSPLANT REJECTION 3
577 URINARY INCONTINENCE 3
578 VAGINAL HAEMORRHAGE 3
579 VIRAL MUTATION IDENTIFIED 3
580 VULVOVAGINAL DISCOMFORT 3
581 VULVOVAGINAL PAIN 3
582 VULVOVAGINAL SWELLING 3
583 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3
584 ABASIA 2
585 ABNORMAL BEHAVIOUR 2
586 ACCIDENT 2
587 ACCIDENTAL OVERDOSE 2
588 ACHROMOTRICHIA ACQUIRED 2
589 ADENOCARCINOMA METASTATIC 2
590 AGGRESSION 2
591 ANAL SQUAMOUS CELL CARCINOMA 2
592 ANGIOEDEMA 2
593 ANKLE FRACTURE 2
594 ANOSMIA 2
595 AORTIC DILATATION 2
596 APHONIA 2
597 APNOEA 2
598 APPETITE DISORDER 2
599 APPLICATION SITE NECROSIS 2
600 APPLICATION SITE OEDEMA 2
601 APPLICATION SITE PARAESTHESIA 2
602 APPLICATION SITE PUSTULES 2
603 ARTERIOSCLEROSIS 2
604 ARTERITIS 2
605 ASCITES 2
606 ATYPICAL PNEUMONIA 2
607 AUTOIMMUNE DISORDER 2
608 AUTOIMMUNE HEPATITIS 2
609 B-CELL LYMPHOMA 2
610 BALANOPOSTHITIS 2
611 BASOSQUAMOUS CARCINOMA 2
612 BASOSQUAMOUS CARCINOMA OF SKIN 2
613 BK VIRUS INFECTION 2
614 BLOOD GLUCOSE DECREASED 2
615 BLOOD MAGNESIUM DECREASED 2
616 BLOOD POTASSIUM DECREASED 2
617 BLOOD PRESSURE INADEQUATELY CONTROLLED 2
618 BLOOD PRESSURE SYSTOLIC INCREASED 2
619 BLOOD SODIUM DECREASED 2
620 BLOOD TEST ABNORMAL 2
621 BLOOD TRIGLYCERIDES INCREASED 2
622 BLOODY DISCHARGE 2
623 BONE DISORDER 2
624 BOWEN^S DISEASE 2
625 BULBAR PALSY 2
626 BURNS SECOND DEGREE 2
627 BURSITIS 2
628 CAPILLARY LEAK SYNDROME 2
629 CARDIAC DISORDER 2
630 CELL DEATH 2
631 CEREBRAL HAEMORRHAGE 2
632 CHOLECYSTITIS INFECTIVE 2
633 CHOLELITHIASIS 2
634 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2
635 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2
636 CLOSTRIDIAL INFECTION 2
637 COMA 2
638 CONJUNCTIVAL OEDEMA 2
639 CORNEAL EROSION 2
640 COVID-19 PNEUMONIA 2
641 CUTANEOUS SARCOIDOSIS 2
642 DEAFNESS UNILATERAL 2
643 DEFORMITY 2
644 DEVICE DISLOCATION 2
645 DISTRIBUTIVE SHOCK 2
646 DIVERTICULITIS 2
647 DRUG DEPENDENCE 2
648 DUODENAL PERFORATION 2
649 DYSSTASIA 2
650 ENERGY INCREASED 2
651 ESCHAR 2
652 EXOSTOSIS 2
653 EXTRA DOSE ADMINISTERED 2
654 EYE INFLAMMATION 2
655 EYE ULCER 2
656 FACE OEDEMA 2
657 FANCONI SYNDROME ACQUIRED 2
658 FEELING JITTERY 2
659 FULL BLOOD COUNT ABNORMAL 2
660 GASTRIC PERFORATION 2
661 GASTROENTERITIS VIRAL 2
662 GASTROINTESTINAL PAIN 2
663 GASTROINTESTINAL ULCER HAEMORRHAGE 2
664 GENITAL HAEMORRHAGE 2
665 GENITAL ULCERATION 2
666 GINGIVAL BLEEDING 2
667 GINGIVAL PAIN 2
668 GINGIVAL SWELLING 2
669 GOUT 2
670 GRAFT VERSUS HOST DISEASE IN SKIN 2
671 HAEMATOCHEZIA 2
672 HAEMATOCRIT DECREASED 2
673 HAEMATOCRIT INCREASED 2
674 HAEMATOMA 2
675 HAEMATURIA 2
676 HAEMOGLOBIN INCREASED 2
677 HAIR COLOUR CHANGES 2
678 HALLUCINATION, VISUAL 2
679 HEAD DISCOMFORT 2
680 HEAD INJURY 2
681 HEART RATE DECREASED 2
682 HEPATIC CYTOLYSIS 2
683 HEPATIC PAIN 2
684 HIP ARTHROPLASTY 2
685 HOSPICE CARE 2
686 HOT FLUSH 2
687 HUMAN HERPESVIRUS 8 INFECTION 2
688 HYPERAESTHESIA 2
689 HYPERVOLAEMIA 2
690 HYPOACUSIS 2
691 HYPOGLYCAEMIA 2
692 ILL-DEFINED DISORDER 2
693 IMMUNE THROMBOCYTOPENIC PURPURA 2
694 IMMUNOSUPPRESSION 2
695 IMPAIRED WORK ABILITY 2
696 INCORRECT PRODUCT ADMINISTRATION DURATION 2
697 INCORRECT ROUTE OF DRUG ADMINISTRATION 2
698 INCREASED APPETITE 2
699 INCREASED UPPER AIRWAY SECRETION 2
700 INFUSION RELATED REACTION 2
701 INJECTION SITE HAEMORRHAGE 2
702 INJECTION SITE PRURITUS 2
703 INJURY 2
704 INSURANCE ISSUE 2
705 INTENTIONAL OVERDOSE 2
706 INTENTIONAL UNDERDOSE 2
707 INTERNAL HAEMORRHAGE 2
708 INTERSTITIAL LUNG DISEASE 2
709 INTERVERTEBRAL DISC CALCIFICATION 2
710 INTESTINAL MASS 2
711 INTRACRANIAL HAEMATOMA 2
712 IRRITABLE BOWEL SYNDROME 2
713 JOINT STIFFNESS 2
714 KELOID SCAR 2
715 KERATITIS 2
716 LIMB INJURY 2
717 LIP DISCOLOURATION 2
718 LIVER DISORDER 2
719 LUNG ABSCESS 2
720 LYMPHOCYTE COUNT DECREASED 2
721 LYMPHOCYTE COUNT INCREASED 2
722 MACULAR SCAR 2
723 MAJOR DEPRESSION 2
724 MASS 2
725 MEAN PLATELET VOLUME INCREASED 2
726 MEMORY IMPAIRMENT 2
727 MENSTRUATION DELAYED 2
728 MENTAL DISORDER 2
729 MENTAL IMPAIRMENT 2
730 METASTASES TO LIVER 2
731 MICTURITION URGENCY 2
732 MOOD ALTERED 2
733 MOUTH HAEMORRHAGE 2
734 MOUTH SWELLING 2
735 MYCOSIS FUNGOIDES 2
736 MYDRIASIS 2
737 MYELODYSPLASTIC SYNDROME 2
738 MYOCARDIAL ISCHAEMIA 2
739 NASAL DISCOMFORT 2
740 NEEDLE ISSUE 2
741 NEOPLASM PROGRESSION 2
742 NEOPLASM SKIN 2
743 NEURALGIA 2
744 NEUROPSYCHIATRIC SYNDROME 2
745 NEUTROPHIL COUNT INCREASED 2
746 NIGHTMARE 2
747 NO THERAPEUTIC RESPONSE 2
748 NODULE 2
749 ORAL CANDIDIASIS 2
750 ORAL DISORDER 2
751 ORF 2
752 ORTHOSTATIC HYPOTENSION 2
753 OTORRHOEA 2
754 PANNICULITIS 2
755 PEMPHIGOID 2
756 PERIORBITAL DISORDER 2
757 PERITONITIS 2
758 PHARYNGEAL DISORDER 2
759 PHARYNGITIS STREPTOCOCCAL 2
760 PHOTOPHOBIA 2
761 PITYRIASIS RUBRA PILARIS 2
762 PLASMACYTOMA 2
763 PNEUMONIA BACTERIAL 2
764 PNEUMOTHORAX TRAUMATIC 2
765 POLYMYALGIA RHEUMATICA 2
766 POOR QUALITY PRODUCT ADMINISTERED 2
767 POROKERATOSIS 2
768 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2
769 PRODUCT ADMINISTRATION INTERRUPTED 2
770 PRODUCT PACKAGING ISSUE 2
771 PRODUCT PHYSICAL ISSUE 2
772 PROSTATITIS 2
773 PROTEIN TOTAL DECREASED 2
774 PRURITUS GENITAL 2
775 PULMONARY FIBROSIS 2
776 PULMONARY MASS 2
777 PURPURA 2
778 QUALITY OF LIFE DECREASED 2
779 RAYNAUD^S PHENOMENON 2
780 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2
781 RED CELL DISTRIBUTION WIDTH INCREASED 2
782 REFUSAL OF TREATMENT BY PATIENT 2
783 SEASONAL ALLERGY 2
784 SINUS CONGESTION 2
785 SKIN ATROPHY 2
786 SKIN INDURATION 2
787 SKIN INJURY 2
788 SKIN MASS 2
789 SNEEZING 2
790 SPEECH DISORDER 2
791 SPINAL FRACTURE 2
792 SPLENOMEGALY 2
793 SPONDYLITIS 2
794 SPUTUM DISCOLOURED 2
795 STAPHYLOCOCCAL SEPSIS 2
796 STAPHYLOCOCCAL SKIN INFECTION 2
797 STREPTOCOCCAL INFECTION 2
798 SUNBURN 2
799 SWELLING OF EYELID 2
800 TELANGIECTASIA 2
801 TEMPERATURE INTOLERANCE 2
802 THERAPEUTIC PRODUCT EFFECT DELAYED 2
803 THIRST 2
804 THYROID DISORDER 2
805 TONGUE BLISTERING 2
806 TOOTH ABSCESS 2
807 TOOTH DISORDER 2
808 TRANSCRIPTION MEDICATION ERROR 2
809 TRANSFUSION 2
810 TRIGEMINAL NEURALGIA 2
811 TUBERCULOSIS 2
812 ULCER HAEMORRHAGE 2
813 URINE ABNORMALITY 2
814 VAGINAL DISCHARGE 2
815 VIRAL INFECTION 2
816 VIROLOGIC FAILURE 2
817 VISUAL ACUITY REDUCED 2
818 VISUAL FIELD DEFECT 2
819 VITAMIN D DEFICIENCY 2
820 WHEELCHAIR USER 2
821 WOUND HAEMORRHAGE 2
822 WOUND INFECTION 2
823 WOUND INFECTION PSEUDOMONAS 2
824 WOUND INFECTION STAPHYLOCOCCAL 2
825 WRONG DOSE 2
826 ABDOMINAL HERNIA 1
827 ABNORMAL FAECES 1
828 ABSCESS LIMB 1
829 ACANTHOLYSIS 1
830 ACANTHOMA 1
831 ACANTHOSIS 1
832 ACTINIC CHEILITIS 1
833 ACUTE CORONARY SYNDROME 1
834 ACUTE LEUKAEMIA 1
835 ACUTE MYELOID LEUKAEMIA 1
836 ACUTE MYOCARDIAL INFARCTION 1
837 ACUTE PRERENAL FAILURE 1
838 ADENOCARCINOMA GASTRIC 1
839 ADMINISTRATION SITE INFLAMMATION 1
840 ADMINISTRATION SITE SWELLING 1
841 ADMINISTRATION SITE ULCER 1
842 ADMINISTRATION SITE WARMTH 1
843 ADRENOCORTICAL INSUFFICIENCY ACUTE 1
844 AFFECTIVE DISORDER 1
845 ALCALIGENES INFECTION 1
846 ALCOHOL INTOLERANCE 1
847 ALCOHOLIC SEIZURE 1
848 ALLERGY TO CHEMICALS 1
849 ALOPECIA AREATA 1
850 ALVEOLITIS ALLERGIC 1
851 AMAUROSIS FUGAX 1
852 ANAL ABSCESS 1
853 ANAL PRURITUS 1
854 ANAL ULCER 1
855 ANAPHYLACTIC REACTION 1
856 ANGER 1
857 ANION GAP INCREASED 1
858 ANKLE ARTHROPLASTY 1
859 ANOGENITAL DYSPLASIA 1
860 ANORECTAL DISCOMFORT 1
861 ANXIETY DISORDER 1
862 AORTIC ANEURYSM 1
863 AORTIC STENOSIS 1
864 AORTIC VALVE CALCIFICATION 1
865 APALLIC SYNDROME 1
866 APHAGIA 1
867 APPENDICITIS 1
868 APPENDICITIS PERFORATED 1
869 APPLICATION SITE ATROPHY 1
870 APPLICATION SITE DERMATITIS 1
871 APPLICATION SITE HYPERAESTHESIA 1
872 APPLICATION SITE INDURATION 1
873 APPLICATION SITE INJURY 1
874 APPLICATION SITE LYMPHADENOPATHY 1
875 APPLICATION SITE PLAQUE 1
876 APPLICATION SITE URTICARIA 1
877 APPLICATION SITE WOUND 1
878 ARTERIOVENOUS MALFORMATION 1
879 ARTHRITIS REACTIVE 1
880 ASPARTATE AMINOTRANSFERASE DECREASED 1
881 ASPIRATION 1
882 ATAXIA 1
883 ATRIAL FLUTTER 1
884 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1
885 ATROPHY 1
886 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1
887 AUTOIMMUNE RETINOPATHY 1
888 AZOTAEMIA 1
889 B-LYMPHOCYTE COUNT DECREASED 1
890 B-LYMPHOCYTE COUNT INCREASED 1
891 BACK DISORDER 1
892 BACTERIAL VAGINOSIS 1
893 BACTEROIDES TEST POSITIVE 1
894 BAND NEUTROPHIL PERCENTAGE DECREASED 1
895 BELL^S PALSY 1
896 BENIGN NEOPLASM OF THYROID GLAND 1
897 BENIGN PROSTATIC HYPERPLASIA 1
898 BIPOLAR DISORDER 1
899 BLADDER PAIN 1
900 BLEPHAROSPASM 1
901 BLINDNESS TRANSIENT 1
902 BLISTER INFECTED 1
903 BLOOD ALCOHOL INCREASED 1
904 BLOOD BICARBONATE DECREASED 1
905 BLOOD BILIRUBIN INCREASED 1
906 BLOOD CHLORIDE INCREASED 1
907 BLOOD CHOLESTEROL INCREASED 1
908 BLOOD CREATININE DECREASED 1
909 BLOOD HIV RNA INCREASED 1
910 BLOOD IMMUNOGLOBULIN E INCREASED 1
911 BLOOD IMMUNOGLOBULIN G DECREASED 1
912 BLOOD IMMUNOGLOBULIN M DECREASED 1
913 BLOOD IMMUNOGLOBULIN M INCREASED 1
914 BLOOD LOSS ANAEMIA 1
915 BLOOD PH INCREASED 1
916 BLOOD PRESSURE DECREASED 1
917 BLOOD TESTOSTERONE INCREASED 1
918 BLOOD THYROID STIMULATING HORMONE DECREASED 1
919 BLOOD UREA DECREASED 1
920 BLOOD UREA INCREASED 1
921 BLOOD VISCOSITY INCREASED 1
922 BODY TEMPERATURE ABNORMAL 1
923 BODY TEMPERATURE DECREASED 1
924 BONE MARROW FAILURE 1
925 BOWEN'S DISEASE 1
926 BRAIN OEDEMA 1
927 BRAIN STEM HAEMORRHAGE 1
928 BREAST CANCER FEMALE 1
929 BREAST PAIN 1
930 BRONCHOPULMONARY ASPERGILLOSIS 1
931 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1
932 BUNDLE BRANCH BLOCK 1
933 BUNDLE BRANCH BLOCK RIGHT 1
934 BURNS THIRD DEGREE 1
935 C-REACTIVE PROTEIN INCREASED 1
936 CACHEXIA 1
937 CALCULUS BLADDER 1
938 CANCER SURGERY 1
939 CARCINOMA IN SITU OF PENIS 1
940 CARDIAC FLUTTER 1
941 CARDIAC PACEMAKER REMOVAL 1
942 CARDIO-RESPIRATORY ARREST 1
943 CARDIOGENIC SHOCK 1
944 CARDIOMYOPATHY 1
945 CAROTID ARTERIOSCLEROSIS 1
946 CAROTID ARTERY ANEURYSM 1
947 CAROTID ARTERY STENOSIS 1
948 CARPAL TUNNEL SYNDROME 1
949 CARTILAGE INJURY 1
950 CATARACT OPERATION 1
951 CEREBELLAR ATROPHY 1
952 CEREBELLAR HAEMORRHAGE 1
953 CEREBRAL DISORDER 1
954 CERVICAL DYSPLASIA 1
955 CERVIX CARCINOMA STAGE III 1
956 CHEMICAL BURN OF GENITALIA 1
957 CHEMICAL BURN OF SKIN 1
958 CHEMICAL BURNS OF EYE 1
959 CHEMICAL INJURY 1
960 CHROMATURIA 1
961 CHROMOSOMAL DELETION 1
962 CHRONIC DISEASE 1
963 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 1
964 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1
965 CIRCADIAN RHYTHM SLEEP DISORDER 1
966 CLAVICLE FRACTURE 1
967 CLOSTRIDIUM DIFFICILE INFECTION 1
968 COLD SWEAT 1
969 COLITIS 1
970 COLON ADENOMA 1
971 COLON CANCER METASTATIC 1
972 COLORECTAL ADENOCARCINOMA 1
973 CONDUCTION DISORDER 1
974 CONJUNCTIVAL HAEMORRHAGE 1
975 CONJUNCTIVITIS VIRAL 1
976 CONTRAINDICATED PRODUCT ADMINISTERED 1
977 CORNEAL OPACITY 1
978 CORONA VIRUS INFECTION 1
979 CORONARY ARTERY STENOSIS 1
980 COSTOCHONDRITIS 1
981 CREATININE RENAL CLEARANCE DECREASED 1
982 CSF PROTEIN ABNORMAL 1
983 CUTANEOUS SYMPTOM 1
984 CUTANEOUS T-CELL LYMPHOMA 1
985 CUTANEOUS T-CELL LYMPHOMA REFRACTORY 1
986 CYSTITIS 1
987 CYSTITIS HAEMORRHAGIC 1
988 CYTOKINE ABNORMAL 1
989 CYTOKINE RELEASE SYNDROME 1
990 CYTOMEGALOVIRUS COLITIS 1
991 CYTOMEGALOVIRUS INFECTION 1
992 CYTOPENIA 1
993 DECREASED IMMUNE RESPONSIVENESS 1
994 DECUBITUS ULCER 1
995 DEEP VEIN THROMBOSIS 1
996 DERMATITIS ACNEIFORM 1
997 DERMATITIS EXFOLIATIVE GENERALISED 1
998 DERMATITIS INFECTED 1
999 DERMATITIS PSORIASIFORM 1